Xiaolong Liu

Dr. Xiaolong Liu

School of life science, Tsinghua University, Beijing, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HJHongqiang Jin
Hongqiang Jin
RZRunqing Zhao
Runqing Zhao
PCPeixin Cui
Peixin Cui
XLXiaolong Liu
Xiaolong Liu
JYJie Yan
Jie Yan
CCChangyan Cao
Changyan Cao

27 April 2023 in Advanced Materials
Verified
Journal Article
Closed access
YZYong‐Dan Zhao
Yong‐Dan Zhao
HAHong‐Wei An
Hong‐Wei An
MMMuhetaerjiang Mamuti
Muhetaerjiang Mamuti
XZXiang‐Zhong Zeng
Xiang‐Zhong Zeng
RZRui Zheng
Rui Zheng
XFXiaohong Fang
Xiaohong Fang

10 February 2022 in Analytical Chemistry
Verified
Journal Article
Closed access
HYHongwei Yang
Hongwei Yang
YWYayun Wu
Yayun Wu
HRHefei Ruan
Hefei Ruan
FGFeng Guo
Feng Guo
YLYuxin Liang
Yuxin Liang
XFXiaohong Fang
Xiaohong Fang

22 September 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
XLXiaolong Liu
Xiaolong Liu
YJYifei Jiang
Yifei Jiang
YCYutong Cui
Yutong Cui
JYJinghe Yuan
Jinghe Yuan
XFXiaohong Fang
Xiaohong Fang
Deep learning has been applied in all stages of single molecule imaging and analysis.

9 January 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
GQGege Qin
Gege Qin
XSXiying Shao
Xiying Shao
XLXiaolong Liu
Xiaolong Liu
JXJiachao Xu
Jiachao Xu
XWXiaojia Wang
Xiaojia Wang
XFXiaohong Fang
Xiaohong Fang
Emerging evidence indicates that intratumor bacteria exist as an active and specific tumor component in many tumor types beyond digestive and respiratory tumors. However, the biological impact and responsible molecules of such local bacteria–tumor direct interaction on cancer therapeutic response remain poorly understood. Trastuzumab is among the most commonly used drugs targeting the receptor tyrosine-protein kinase erbB-2 (ErbB2) in breast cancer, but its resistance is inevitable, severely limiting its clinical effectiveness. Here, we demonstrate that the quorum-sensing signaling molecule N-(3-oxo-dodecanoyl) homoserine lactone (3oc), a chemical compound released by Pseudomonas aeruginosa ( P. aeruginosa ), one tumor-resident bacteria with a relative high abundance in breast cancer, promotes breast cancer cell resistance to trastuzumab. Mechanically, 3oc directly leads to spontaneous dimerization of the transforming growth factor β (TGF-β) type II serine/threonine kinase receptor on the cell membrane in a ligand-independent manner. The 3oc-induced TGF-β signaling subsequently triggers ErbB2 phosphorylation and its downstream target activation, overcoming the inhibition effect of trastuzumab on ErbB2. With specific real-time qPCR, fluorescence in situ hybridization imaging, and liquid chromatography ionization tandem mass spectrometry analyses of clinical samples, we confirmed that P. aeruginosa and its signaling molecule 3oc exist in breast cancer tissues and there is a clinical correlation between P. aeruginosa colonization and trastuzumab resistance. This work expands the biological functions of intratumor bacteria in cancer treatment responsiveness and provides a unique perspective for overcoming trastuzumab resistance.

12 February 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
WLWeifeng Liu
Weifeng Liu
HYHongwei Yang
Hongwei Yang
XLXiaolong Liu
Xiaolong Liu
HCHeqi Cai
Heqi Cai
YBYuting Bao
Yuting Bao
XFXiaohong Fang
Xiaohong Fang